-
It is mutually understood and agreed that the Clinical
Investigators Directory (CID) and database information will be distributed
only to pharmaceutical or research oriented companies. It is also
mutually understood and agreed that the World Wide Web is open to
all subscribers. Therefore, RIS is unable to limit the accessibility
of your listing on the RIS web-site.
-
Membership: A membership in RIS will include a listing
and a copy of the CID. RIS may refuse to publish any potential listing
at its sole discretion. Any money paid in advance by you will be returned
if RIS refuses to publish the listing.
-
Subsequent Issues: This application for registration
is for the 2008 computerized database and the 2008 edition of the
CID. Listing in subsequent issues will be at the rate in effect at
that time.
-
Cost: You agree to pay RIS, in advance, $425 for inclusion
in the 2008 computerized database and 2008 CID and other complimentary
services prior to the promotion deadline of December 31, 2008. If this
amount is not paid, RIS may, at its own discretion cancel the listing.
-
Refund for Termination: The 2008 or subsequent editions
of the CID, or a listing, may be terminated by RIS as provided herein--or
by you--by giving written notice to RIS at least 48 hours prior to
the closing date for the directory. If RIS decides not to publish
the CID, any money prepaid by you to RIS for that particular edition
will be refunded.
-
No Refund After Closing Date: Owing to the nature
and distribution of the CID, there will be no refund available if
you wish to change or cancel a listing after the cut off date.
-
Warranties: You warrant that you are a qualified clinical
investigator and further warrant (1) that you are in compliance with
any applicable local, state or federal laws that govern your practice
including licensing requirements; and (2) that you will hold RIS harmless
from any and all claims and demands asserted against RIS by reason
of the falsity of the foregoing representations, breach of any warranties
or by reason of the falsity or misleading nature of information you
may supply to RIS. You agree to indemnify RIS for any damages, costs
and attorney's fees associated with any such claims and demands asserted
against RIS.
-
Factual Information: Information for your listing
is to be provided by you on the attached enrollment form. You assume
full responsibility for the factual nature of the information you
provide. Furthermore, it is understood that any misrepresentation
on your part, whether by mistake or deliberate, may be grounds for
rejection of this application or listing in future editions of the
CID. You give permission to RIS to verify any of the information supplied
for inclusion in the directory. RIS may license third parties to publish,
reproduce or duplicate any material contained within the directory
without the limits of paragraph 1 above. RIS hereby license you to
reproduce or copy material about you which was ordered, subject to
limitations and/or the will of RIS. Once the data regarding an organization
is accepted for publication, it will become the property of RIS. All
information compiled will become part of our database.
-
Personal Data: It is agreed that a draft copy of your
listing(s) will be returned to you within 15 working days from receipt
by RIS of your personal data form. You agree to return the draft copy
with corrections within 10 days. If the draft copy is not returned
within 10 days, RIS may assume that the listing is correct.
-
Printing Errors: In the event of any printing error
in your data in the CID, its placement in the CID, or printing errors
in other material published in the CID, you shall be limited only
to a refund of the prepaid subscription fee.
-
Revisions: RIS reserves the right to revise its policies
and practices including, but not limited to, revision of directory
headings, listings and any other information contained in it and to
alter distribution of the directory in the pharmaceutical research
field.
-
Assignment: This agreement may not be assigned without
the consent of RIS.
-
Entire Contract: Upon acceptance by RIS, this agreement
constitutes the entire agreement between you and RIS and neither shall
be bound by any terms, conditions or representations not herein contained.
Neither you nor RIS is bound to any verbal agreement or special arrangement
contrary or in addition to the terms of this written agreement.
